Filing Details
- Accession Number:
- 0000899243-20-026974
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-10-02 19:43:35
- Reporting Period:
- 2020-09-30
- Accepted Time:
- 2020-10-02 19:43:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1731831 | Eidos Therapeutics Inc. | EIDX | Pharmaceutical Preparations (2834) | 463733671 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1742587 | Uma Sinha | C/O Eidos Therapeutics, Inc. 101 Montgomery Street, Suite 2000 San Francisco CA 94104 | Chief Scientific Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-09-30 | 69 | $52.08 | 331,456 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-09-30 | 100 | $52.00 | 331,356 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-10-01 | 4,831 | $52.35 | 326,525 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 Sales Plan adopted by the Reporting Person on August 13, 2020.
- Represents the weighted average sale price of the shares sold ranging from $52.05 to $53.00 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
